Literature DB >> 31087464

Review of autoimmune blistering diseases: the Pemphigoid diseases.

B S Daniel1,2,3, D F Murrell2,3.   

Abstract

Autoimmune Blistering Diseases of the Pemphigoid type is characterised by sub-epidermal blisters (SEB) with circulating autoantibodies against components of the basement membrane zone (BMZ). The main disorders to date include bullous pemphigoid (BP), pemphigoid gestationis, mucous membrane pemphigoid (MMP), epidermolysis bullosa acquisita (EBA), linear IgA disease (LABD), dermatitis herpetiformis (DH), lichen planus pemphigoides and bullous lupus. This is in contrast to pemphigus and related disorders, which demonstrate intraepidermal acantholysis and a positive Nikolsky sign. The classification and management is based on clinical, histological and direct and indirect immunofluorescence findings. There are, however, overlapping clinical and histological features between the conditions and clinical heterogeneity within each disease.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Year:  2019        PMID: 31087464     DOI: 10.1111/jdv.15679

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  12 in total

1.  Epidermolysis bullosa acquisita.

Authors:  Denise Miyamoto; Juliana Olivieri Gordilho; Claudia Giuli Santi; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2022-06-11       Impact factor: 2.113

2.  Diagnostic Value and Practicability of Serration Pattern Analysis by Direct Immunofluorescence Microscopy in Pemphigoid Diseases.

Authors:  Maike M Holtsche; Nina van Beek; Axel Künstner; Hauke Busch; Detlef Zillikens; Enno Schmidt
Journal:  Acta Derm Venereol       Date:  2021-03-09       Impact factor: 3.875

3.  Late-onset 'sloughing esophagitis' (esophagitis dissecans superficialis) associated with bullous pemphigoid.

Authors:  Eliana Carolina Morel-Cerda; Bryan Adrian Priego-Parra; Peter Grube-Pagola; Jose Maria Remes-Troche
Journal:  BMJ Case Rep       Date:  2020-07-08

4.  A case of toxic epidermal necrosis-like cutaneous eruption as the first manifestation and clue to the diagnosis of systemic lupus erythematosus: A case report.

Authors:  Hanieh Zargham; Stephanie Ghazal; Kevin Watters; Khue Huu Nguyen
Journal:  SAGE Open Med Case Rep       Date:  2020-07-15

Review 5.  Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges.

Authors:  Nicolas Kluger; Anna Pankakoski; Jaana Panelius
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-01-21

6.  Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.

Authors:  Dario Didona; Luca Scarsella; Milad Fehresti; Farzan Solimani; Hazem A Juratli; Manuel Göbel; Stefan Mühlenbein; Lily Holiangu; Josquin Pieper; Vera Korff; Thomas Schmidt; Cassian Sitaru; Rüdiger Eming; Michael Hertl; Robert Pollmann
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

7.  A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes.

Authors:  Anahita Kate; Swapna Shanbhag; Pragnya Rao Donthineni; Sayan Basu
Journal:  F1000Res       Date:  2021-11-25

8.  Tense blisters in a previously healthy young woman.

Authors:  Vipawee S Chat; James S Petit; Loretta S Davis
Journal:  JAAD Case Rep       Date:  2021-06-24

Review 9.  Keratin Biomaterials in Skin Wound Healing, an Old Player in Modern Medicine: A Mini Review.

Authors:  Marek Konop; Mateusz Rybka; Adrian Drapała
Journal:  Pharmaceutics       Date:  2021-11-28       Impact factor: 6.321

10.  Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.

Authors:  Yihua Zhang; Qiuyun Xu; Lihong Chen; Jiawen Chen; Jing Zhang; Ying Zou; Ting Gong; Chao Ji
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.